Calcium (Ca²⁺) homeostasis is essential for neuronal survival, synaptic transmission, and cellular signaling. Progressive Supranuclear Palsy (PSP), a 4-repeat tauopathy characterized by progressive postural instability, supranuclear gaze palsy, and cognitive decline, involves significant calcium dysregulation that contributes to neuronal vulnerability, tau pathology, and progressive neurodegeneration [1][2]. While calcium dysregulation has been extensively studied in Alzheimer's disease (AD) and Parkinson's disease (PD), emerging evidence specifically links calcium mishandling to the selective vulnerability of brainstem nuclei, basal ganglia, and cortical neurons in PSP [3]. [@pchitskaya2023]
The precise mechanisms underlying calcium dysregulation in PSP involve multiple interconnected pathways: voltage-gated calcium channel (VGCC) alterations, impaired mitochondrial calcium buffering, endoplasmic reticulum (ER) stress, store-operated calcium entry (SOCE) dysfunction, and excitotoxic mechanisms. These disturbances create a vicious cycle that accelerates tau hyperphosphorylation, aggregation, and propagation while simultaneously promoting neuronal apoptosis. [@choi2024]
```mermaid
flowchart TD
subgraph Extracellular
A["Extracellular Ca2+"]
end
subgraph Membrane
B["Voltage-Gated<br/>Ca2+ Channels"]
C["L-type Ca2+ Channel"]
D["P/Q-type Ca2+ Channel"]
E["T-type Ca2+ Channel"]
end
Calcium (Ca²⁺) homeostasis is essential for neuronal survival, synaptic transmission, and cellular signaling. Progressive Supranuclear Palsy (PSP), a 4-repeat tauopathy characterized by progressive postural instability, supranuclear gaze palsy, and cognitive decline, involves significant calcium dysregulation that contributes to neuronal vulnerability, tau pathology, and progressive neurodegeneration [1][2]. While calcium dysregulation has been extensively studied in Alzheimer's disease (AD) and Parkinson's disease (PD), emerging evidence specifically links calcium mishandling to the selective vulnerability of brainstem nuclei, basal ganglia, and cortical neurons in PSP [3]. [@pchitskaya2023]
The precise mechanisms underlying calcium dysregulation in PSP involve multiple interconnected pathways: voltage-gated calcium channel (VGCC) alterations, impaired mitochondrial calcium buffering, endoplasmic reticulum (ER) stress, store-operated calcium entry (SOCE) dysfunction, and excitotoxic mechanisms. These disturbances create a vicious cycle that accelerates tau hyperphosphorylation, aggregation, and propagation while simultaneously promoting neuronal apoptosis. [@choi2024]
L-type voltage-gated calcium channels (Cav1.2, encoded by [CACNA1C](/genes/cacna1c)) are prominently expressed in neurons of the substantia nigra, basal ganglia, and brainstem nuclei—regions particularly affected in PSP [4]. Post-mortem studies of PSP brain tissue demonstrate increased L-type channel expression and enhanced calcium influx in vulnerable neuronal populations. This upregulation appears to be a compensatory response to cellular stress, but paradoxically contributes to calcium overload and subsequent neurotoxicity [5]. [@hoozemans2022]
The dysregulation of L-type channels in PSP shares similarities with findings in PD, where Cav1.3 (encoded by [CACNA1D](/genes/cacna1d)) channels have been extensively studied. However, PSP demonstrates a distinct pattern with preferential involvement of Cav1.2-containing channels in brainstem motor nuclei [6]. [@bezprozvanny2023]
P/Q-type calcium channels (Cav2.1, encoded by [CACNA1A](/genes/cacna1a)) and N-type channels (Cav2.2, encoded by [CACNA1B](/genes/cacna1b)) regulate neurotransmitter release at synaptic terminals. In PSP, these channels exhibit altered phosphorylation states and trafficking, leading to dysregulated synaptic calcium dynamics. The resulting imbalance between excitatory and inhibitory neurotransmission contributes to the characteristic movement disorders observed in PSP, including bradykinesia, rigidity, and supranuclear gaze palsy [7]. [@surmeier2024]
T-type calcium channels (Cav3.1, Cav3.2, Cav3.3) generate low-threshold calcium spikes important for neuronal excitability. Studies in PSP models demonstrate enhanced T-type channel activity, particularly in subthalamic nucleus neurons. This hyperactivity contributes to abnormal burst firing patterns and network oscillations that underlie the parkinsonian features of PSP [8].
Mitochondria serve as critical calcium buffers, sequestering excess cytosolic calcium during periods of elevated influx. In PSP, multiple factors converge to overwhelm mitochondrial calcium handling capacity:
The mitochondria-associated ER membrane (MAM) is a specialized subdomain where ER and mitochondria form tight contacts, enabling direct calcium transfer. In PSP, tau pathology disrupts MAM integrity, leading to abnormal calcium transfer between these organelles. This disruption creates a bidirectional pathogenic loop: tau accumulation disrupts calcium homeostasis, while calcium dysregulation promotes further tau pathology [9][10].
The [Na⁺/Ca²⁺ Exchanger (NCX)](/proteins/ncx-protein) and mitochondrial calcium exchangers like NCLX play crucial roles in mitochondrial calcium efflux. Dysfunction of these exchangers in PSP contributes to mitochondrial calcium overload and subsequent bioenergetic failure [11].
Excessive mitochondrial calcium accumulation triggers the mitochondrial permeability transition pore (mPTP), leading to:
The endoplasmic reticulum (ER) serves as the primary intracellular calcium reservoir. In PSP, ER calcium stores become progressively depleted through multiple mechanisms:
ER calcium depletion triggers the unfolded protein response (UPR), a compensatory mechanism that initially attempts to restore ER homeostasis but becomes maladaptive when prolonged. In PSP, chronic UPR activation leads to:
When ER calcium stores are depleted, store-operated calcium entry (SOCE) is activated through the STIM1-Orai1 mechanism. [STIM1](/proteins/stim1-protein) senses ER calcium depletion and activates plasma membrane Orai1 channels, allowing extracellular calcium influx.
In PSP, chronic ER calcium depletion leads to sustained SOCE activation. While initially protective, prolonged SOCE contributes to:
Excitotoxicity—excessive glutamate receptor activation—represents a major consequence of calcium dysregulation in PSP. The excessive calcium influx through VGCCs and SOCE primes neurons for glutamate-induced excitotoxicity:
Excitotoxicity in PSP differs from that observed in corticobasal syndrome (CBS) in several key aspects:
| Feature | Alzheimer's Disease | PSP |
|---------|-------------------|-----|
| Primary calcium dysregulation site | Cortical neurons, hippocampus | Brainstem nuclei, basal ganglia |
| Channel focus | L-type, NMDA receptors | P/Q-type, T-type, L-type |
| ER stress | Prominent (Aβ toxicity) | Moderate |
| Mitochondrial dysfunction | Severe | Severe |
| Calcium buffering proteins | Calbindin reduction | Parvalbumin alterations |
While [Calcium Dysregulation in Alzheimer's Disease](/mechanisms/calcium-dysregulation-ad) prominently features amyloid-β-mediated toxicity and hippocampal vulnerability, PSP calcium dysregulation is more closely linked to tau pathology and brainstem-selective vulnerability [14].
| Feature | Parkinson's Disease | PSP |
|---------|---------------------|-----|
| Primary affected region | Substantia nigra pars compacta | Substantia nigra pars reticulata, brainstem |
| Channel focus | L-type (Cav1.3) | Multiple VGCCs |
| Mitochondrial pathway | Complex I deficiency | Multiple complexes |
| Calcium-protein interactions | α-Synuclein | Tau protein |
The [Calcium Signaling Dysregulation in Parkinson's Disease](/mechanisms/calcium-dysregulation-parkinsons) page provides comprehensive PD-specific mechanisms. Notably, both PSP and PD involve substantia nigra vulnerability, but the pattern of calcium dysregulation differs in channel subtype involvement and regional distribution [15].
Given the central role of calcium dysregulation in PSP pathogenesis, calcium channel modulators represent rational therapeutic targets:
Drugs targeting mitochondrial calcium handling show potential for PSP:
Reducing ER calcium depletion and UPR activation:
Calcium dysregulation in PSP represents a complex, multifactorial pathology involving:
These mechanisms create a self-perpetuating cycle that accelerates neurodegeneration in PSP-affected brain regions. The comparison with AD and PD reveals both shared features and disease-specific patterns, highlighting the importance of understanding calcium dysregulation as a therapeutic target for PSP and related neurodegenerative disorders.
The following diagram shows the key molecular relationships involving Calcium Dysregulation in Progressive Supranuclear Palsy discovered through SciDEX knowledge graph analysis: